Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
NCT06244355 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-06
Summary
The objective is to study the phenotypic, functional and metabolomic characteristics of neutrophils circulating subpopulations in lung cancer patients, and to compare them to a control group of healthy volunteers. A blood sample will be taken before the first treatment session for the lung cancer patient and a second blood sample will be taken during the first evaluation visit.
The investigators hypothesize that there may be different circulating neutrophil subpopulations in patients with metastatic non-small cell lung cancer (NSCLC) involved in tumor progression and resistance to immunotherapy.
Conditions
Interventions
- OTHER
-
Extra blood tubes
Extra blood tubes
Sponsors & Collaborators
-
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Marie WISLEZ, Pr · Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-12
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-31
Countries
- France
Study Locations
More Related Trials
-
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
NCT06833229 ·Status: RECRUITING
-
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)
NCT03816657 ·Status: UNKNOWN
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
NCT07242482 ·Status: NOT_YET_RECRUITING
-
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
NCT06833632 ·Status: RECRUITING
-
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
NCT00188214 ·Status: COMPLETED ·Phase: PHASE2
-
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
NCT01279408 ·Status: COMPLETED
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
NCT06974097 ·Status: NOT_YET_RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02412384 ·Status: COMPLETED
-
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
NCT05404022 ·Status: COMPLETED ·Phase: NA
-
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
NCT04761640 ·Status: UNKNOWN
-
Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
NCT02821949 ·Status: UNKNOWN
-
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
NCT02202655 ·Status: UNKNOWN
-
Circulating Tumor Cells in Lung Cancer
NCT01658332 ·Status: TERMINATED ·Phase: NA
-
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
NCT03563482 ·Status: UNKNOWN ·Phase: NA
-
Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment
NCT05306652 ·Status: RECRUITING ·Phase: NA
-
Microbiota and the Lung Cancer
NCT03068663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
NCT05985330 ·Status: RECRUITING
-
Mechanisms of Immunosurveillance for Lung Cancer
NCT01710319 ·Status: COMPLETED
-
PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer
NCT02827344 ·Status: COMPLETED
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
Lung Cancer Detection by Measuring Monocyte Activity
NCT02090166 ·Status: UNKNOWN ·Phase: NA
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED